Reprogramming Natural Killer Cells for Cancer Immunotherapy

Explore the cutting-edge field of natural killer (NK) cell reprogramming for cancer immunotherapy in this 31-minute webinar presented by Dr. Sandro Matosevic, an associate professor at Purdue University. Discover the potential of NK cells as safer alternatives to T cells in cancer treatment, and learn about innovative genetic engineering approaches aimed at enhancing their anti-tumor function, metabolism, and persistence. Delve into the challenges of targeting aggressive solid tumors and the strategies being developed to overcome immunosuppression in the tumor microenvironment. Gain insights into novel therapeutic modulation techniques designed to boost NK cell immune responses, with the ultimate goal of effectively treating currently incurable cancers. After watching, registered Labroots members can earn PACE credits valid until October 04, 2025.

Reprogramming Natural Killer Cells for Cancer Immunotherapy